CAS: Where Science and Strategy Converge

More Blog Articles

Optimizing AI for improved retrosynthesis predictions

May 28, 2021

Find a better route: Optimizing AI for more novel synthetic predictions

AI and machine learning models aid in retrosynthetic planning, but are limited by the training data they have seen. Read on to learn about ways to generate novel predictions by ensuring your data has the necessary diversity and quality to optimize key synthetic planning initiatives.

Pfizer Covid Vaccine approved for 12-15 year olds

May 10, 2021

Latest data on the safety and effectiveness of COVID-19 vaccines in children

Information covering CDC recommendation of pediatric COVID-19 vaccine for children ages 5-11, and original emergency use authorization from May 2021 for children 12-15.

Novel oligonucleotide thumbnail image

April 12, 2021

Novel oligonucleotide with application in mRNA vaccine quality control gets 250 millionth CAS Registry Number

Novel oligonucleotide from Moderna, with application in mRNA vaccine quality control, marks the 250 millionth substance registration in CAS REGISTRY.

Subscribe to CAS Blog

Your privacy is important to CAS. More detail about how we use your information is in our privacy policy.